Management of Hepatocellular Carcinoma: Bangladesh Perspective.
Management of Hepatocellular Carcinoma: Bangladesh Perspective.
复制标题
DOI：
10.5005/jp-journals-10018-1258
复制
发表时间：
2018-01
期刊：
影响因子：
--
通讯作者：
Noor-E-Alam SM
中科院分区：
文献类型：
--
作者：
Noor-E-Alam SM
孟加拉国是肝细胞癌（HCC）负担最重的国家之一。肝细胞癌是该国第三大常见癌症，仅次于肺癌和胃癌。在孟加拉国，乙型肝炎病毒（HBV）导致66%的HCC。在孟加拉国，乙型肝炎病毒和丙型肝炎病毒（HCV）的推定患病率可能分别高达5.4%和0.84%，肝病占公立医学院内科病房住院人数的8%至12%。在这篇小型综述中，我想从孟加拉国的角度强调HBV和HCV在HCC发展和HCC治疗中的影响。如何引用本文：Noor-E-Alam SM。肝细胞癌的治疗：孟加拉国的观点。中华肝病杂志，2018;8(1):52-53。
Bangladesh is one of the countries facing huge burden of hepatocellular carcinoma (HCC). Hepatocellular carcinoma is the third commonest cancer in the country and it is just behind to cancer of the lung and cancer of the stomach. Hepatitis B virus (HBV) is responsible for 66% of HCC in Bangladesh. Presumptive prevalence of HBV and hepatitis C virus (HCV) may be as high as 5.4 and 0.84%, respectively, in Bangladesh, and liver diseases occupied 8 to 12% of admission in medicine wards of Public Medical College. In this mini review, I would like to highlight the impact of HBV and HCV in the development of HCC and the management of HCC from a Bangladesh perspective. How to cite this article: Noor-E-Alam SM. Management of Hepatocellular Carcinoma: Bangladesh Perspective. Euroasian J Hepato-Gastroenterol 2018;8(1):52-53.